Developer docs
API playgroundTry for free, no card

Search company profiles

Chr. Hansen

Full company profile

uuid000msia

Namestring
Chr. Hansen
Legal namestring
Chr. Hansen Holding A/S
Websiteurl
chr-hansen.com
Company typeenum
Public
Founded yearint
1878
Descriptiontext

Chr. Hansen Holding A/S is a Danish bioscience company founded in 1878 and headquartered in Hørsholm, Denmark, that develops natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. Its core technology is biosolutions based on microbial fermentation, enzymes, bacterial cultures, and natural food colorings derived from biological sources — including lactic acid bacteria for dairy and plant-based fermentation, IP-protected probiotic strains such as BB-12™, protective cultures branded as FreshQ® 5.0, plant- and algae-based colorants (beetroot, turmeric, spirulina, anthocyanins), silage inoculants, and feed enzymes. The company's product portfolio spans Food & Beverages (cultures, enzymes, natural colors), Human Health (probiotics and microbiome solutions), Animal & Plant (silage inoculants, feed enzymes, bio-based crop protection), Bioenergy, Household Care, and Industrial Bioprocessing.

Chr. Hansen operates as a B2B ingredient supplier, selling microbial ingredients, enzymes, and natural food colors directly to enterprise food, nutraceutical, cosmetic, and agricultural manufacturers. Revenue is generated through volume-based ingredient supply and licensing/royalty arrangements on proprietary strains, with quote-based pricing typical for industrial ingredient customers. The company leads the global food cultures market with a 24-28% share, supplies fermentation scale and IP-protected strains to major food and beverage producers including Danone, Nestlé, and Yakult Honsha, and runs the Feed Enzyme Alliance in partnership with dsm-firmenich (now brought in-house via Novonesis's 2025 acquisition). Its go-to-market combines enterprise field sales, clinical R&D investment to substantiate health claims, strategic co-development partnerships with major food companies, and downstream distribution via hypermarkets and supermarkets for finished probiotic products.

Following its December 2023 merger with Novozymes, Chr. Hansen operates as a wholly-owned subsidiary of Novonesis A/S (NASDAQ Copenhagen: NVZMY), a combined bioscience group targeting a €60 billion biosolutions market opportunity and reporting $4.92 billion in FY2025 revenue with 7% organic growth in Q1 2026.

Short descriptiontext

Chr. Hansen is a Danish bioscience company that develops microbial cultures, enzymes, natural food colors, and probiotic strains for enterprise customers across the food, nutritional, pharmaceutical, and agricultural industries. It operates as a wholly-owned subsidiary of Novonesis following the 2023 merger with Novozymes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHørsholm, Denmark
HQ citystring
Hørsholm
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbial food cultures, probiotic ingredients, natural food colors, food enzymes, biosolutions fermentation
Industry8 codes
1Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases)
CodeAFAJAJAEPrimaryYes
2Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryNo
3Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing
CodeAFAHADAJPrimaryNo
4Probiotic & Live-Culture Beverage Production (Shots, Tonics)
CodeAFAFAHAEPrimaryNo
5Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics)
CodeAFAKAJAHPrimaryNo
6Probiotic/Prebiotic Functional Beverage Production (Non-Fermented)
CodeAFAFAFAEPrimaryNo
7Swine Specialty/Functional Feed (Gut Health, Probiotics, Acidifiers, Enzymes)
CodeAFADABAIPrimaryNo
8Probiotics (Strains, Spore-Formers, Synbiotic Components)
CodeAFAJAKAEPrimaryNo
NAICS code2 codes
  • Food Manufacturing311
  • Dairy Product Manufacturing3115
SIC code3 codes
  • Food And Kindred Products2000
  • Dairy Products2020
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Industrial Biotechnology / Food Bioscience Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Probiotic ingredients B2B
TypeSubscription Recurring
Description

Chr. Hansen supplies probiotic ingredients to food, nutraceutical, and cosmetic manufacturers through fermentation scale, IP-protected strains, and B2B partnerships

fortunebusinessinsights.com
2Natural food colors
TypeSubscription Recurring
Description

Major manufacturers including Chr. Hansen maintain competitive advantages through integrated sourcing networks, proprietary processing capabilities, and economies of scale for natural food coloring ingredients

fmiblog.com
3Food cultures and bacterial cultures
TypeLicensing Royalties
Description

Supply of lactic acid bacteria and microbial food cultures for dairy and plant-based dairy alternatives, with Chr. Hansen leading the competitive landscape with 24-28% market share

openpr.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Chr. Hansen manufactures and sells microbial cultures, food enzymes, natural food colors, and probiotic ingredients for B2B customers across food & beverage, human health, animal nutrition, and agricultural industries. The portfolio includes the BB-12™ probiotic strain, FreshQ® 5.0 protective cultures, lactic acid bacteria for dairy fermentation, silage inoculants, and spirulina-based colorants, organized into biosolutions verticals including Food & Beverages, Human Health, Animal & Plant, Bioenergy, Household Care, and Industrial Bioprocessing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Leading 24-28% market share in global food cultures market
+1 more record
Product overview1 text field

Chr. Hansen (now part of Novonesis following its merger with Novozymes in 2023-2024) operates as a biosolutions company offering a broad portfolio of microbial ingredients, enzymes, and natural food colors. The company's offerings span multiple industry verticals including Food & Beverages (bacterial cultures, food enzymes, natural colors), Human Health (probiotics including the documented BB-12™ strain), Animal & Plant (silage inoculants, feed enzymes), Bioenergy (enzymes for biofuel production), Household Care, and Industrial Bioprocessing. The portfolio includes platform products like FreshQ® 5.0 protective cultures for clean-label preservation. The combined entity positions itself as a leader in biosolutions addressing food systems, health, and sustainability challenges.

Product and service2 records
1BB-12™ Probiotic Strain
CategoryHuman health probiotic ingredient
Description

The world's most documented Bifidobacterium probiotic strain, used in dietary supplements, functional foods, and beverages for gut health applications. Targeted at human health manufacturers and nutraceutical brands.

2FreshQ® 5.0 Protective Cultures
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Novonesis and dsm-firmenich have worked together for over 25 years on innovating and distributing enzymes for animals as the Feed Enzyme Alliance. Novonesis acquired dsm-firmenich's animal feed enzyme business, bringing sales and distribution activities under the same roof as research and innovation.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Bio-based crop protection partnership between UPL Ltd. and Chr. Hansen Holding A/S, reflecting the industry's shift toward sustainable and resistance-managed formulations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-21
Description

Danone teamed up with Chr. Hansen on dairy and plant-based innovation as part of the Partner for Growth initiative, focusing on developing new probiotic and culture solutions for dairy and plant-based products.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Now merged with Chr. Hansen to form Novonesis. Was historically the most direct peer in industrial enzymes and microbial solutions, serving overlapping food, beverage, animal nutrition, and bioenergy customers globally.

TypeDirect peer
Description

Privately held French global leader in yeast and fermentation products. Directly comparable as a B2B supplier of microbial cultures, probiotics, and fermentation ingredients to food, bakery, and nutraceutical manufacturers.

TypeDirect peer
Description

Canadian family-owned yeast and bacteria producer with a major probiotics and fermented functional ingredients business. Overlaps with Chr. Hansen in dairy cultures, human probiotics (incl. L. rhamnosus GG), and animal nutrition.

TypeDirect peer
Description

Dutch-Swiss specialty nutrition and health ingredients major; 25-year Feed Enzyme Alliance partner with Chr. Hansen before divesting animal feed enzymes to Novonesis. Comparable across animal nutrition, human health probiotics (i-Health), and food enzymes.

TypeBroad incumbent
Description

Global ingredient major following the DuPont Nutrition & Biosciences merger; offers cultures, enzymes, and probiotics through the Health & Biosciences division. Competes with Chr. Hansen across dairy cultures and food enzymes for major CPG customers.

TypeBroad incumbent
Description

Irish taste & nutrition major serving food and beverage manufacturers. Comparable as a broad-line B2B ingredient supplier with probiotics, enzymes, and functional ingredient portfolios competing for similar CPG wallet share.

TypeDirect peer
Description

Dutch specialty ingredient company producing lactic acid, functional ingredients, and microbial solutions for food and personal care. Directly comparable in dairy cultures and fermentation-derived food ingredients.

TypeRegional player
Description

Baking yeast and ingredient arm of Associated British Foods. Comparable as a global microbial/baking ingredient supplier with overlapping food cultures and bakery ingredient customers.

TypeBroad incumbent
Description

Global agribusiness major with a Human Nutrition and Health & Wellness ingredients portfolio including probiotics (Biopolis) and natural colors. Comparable as a broad-line supplier to food, beverage, and nutraceutical manufacturers.

TypeEmerging player
Description

German specialty chemicals company with a probiotics (Evonik Probiotics) and animal nutrition business. Overlaps with Chr. Hansen in animal health probiotics and gut-health ingredients, serving feed and supplement markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chr. Hansen

Industrial Biotechnology / Food Bioscience Ingredientschr-hansen.com

Chr. Hansen is a Danish bioscience company that develops microbial cultures, enzymes, natural food colors, and probiotic strains for enterprise customers across the food, nutritional, pharmaceutical, and agricultural industries. It operates as a wholly-owned subsidiary of Novonesis following the 2023 merger with Novozymes.

What Chr. Hansen does

Chr. Hansen Holding A/S is a Danish bioscience company founded in 1878 and headquartered in Hørsholm, Denmark, that develops natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. Its core technology is biosolutions based on microbial fermentation, enzymes, bacterial cultures, and natural food colorings derived from biological sources — including lactic acid bacteria for dairy and plant-based fermentation, IP-protected probiotic strains such as BB-12™, protective cultures branded as FreshQ® 5.0, plant- and algae-based colorants (beetroot, turmeric, spirulina, anthocyanins), silage inoculants, and feed enzymes. The company's product portfolio spans Food & Beverages (cultures, enzymes, natural colors), Human Health (probiotics and microbiome solutions), Animal & Plant (silage inoculants, feed enzymes, bio-based crop protection), Bioenergy, Household Care, and Industrial Bioprocessing.

Chr. Hansen operates as a B2B ingredient supplier, selling microbial ingredients, enzymes, and natural food colors directly to enterprise food, nutraceutical, cosmetic, and agricultural manufacturers. Revenue is generated through volume-based ingredient supply and licensing/royalty arrangements on proprietary strains, with quote-based pricing typical for industrial ingredient customers. The company leads the global food cultures market with a 24-28% share, supplies fermentation scale and IP-protected strains to major food and beverage producers including Danone, Nestlé, and Yakult Honsha, and runs the Feed Enzyme Alliance in partnership with dsm-firmenich (now brought in-house via Novonesis's 2025 acquisition). Its go-to-market combines enterprise field sales, clinical R&D investment to substantiate health claims, strategic co-development partnerships with major food companies, and downstream distribution via hypermarkets and supermarkets for finished probiotic products.

Following its December 2023 merger with Novozymes, Chr. Hansen operates as a wholly-owned subsidiary of Novonesis A/S (NASDAQ Copenhagen: NVZMY), a combined bioscience group targeting a €60 billion biosolutions market opportunity and reporting $4.92 billion in FY2025 revenue with 7% organic growth in Q1 2026.

Chr. Hansen firmographics

Firmographics
Name
Chr. Hansen
Legal name
Chr. Hansen Holding A/S
Website
https://chr-hansen.com
Company type
Public
Founded year
1878
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Chr. Hansen is a Danish bioscience company that develops microbial cultures, enzymes, natural food colors, and probiotic strains for enterprise customers across the food, nutritional, pharmaceutical, and agricultural industries. It operates as a wholly-owned subsidiary of Novonesis following the 2023 merger with Novozymes.
Ownership category
akta.pro rank

Chr. Hansen industry classification

Industry
Product category
Industrial Biotechnology / Food Bioscience Ingredients
NAICS
Food Manufacturing (311), Dairy Product Manufacturing (3115)
SIC
Food And Kindred Products (2000), Dairy Products (2020), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro primary industry
Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE)
akta.pro secondary industries
Probiotics & Digestive Health Supplements (CRADAGAF), Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing (AFAHADAJ), Probiotic & Live-Culture Beverage Production (Shots, Tonics) (AFAFAHAE), Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics) (AFAKAJAH), Probiotic/Prebiotic Functional Beverage Production (Non-Fermented) (AFAFAFAE), Swine Specialty/Functional Feed (Gut Health, Probiotics, Acidifiers, Enzymes) (AFADABAI), Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

Keywords

  • Microbial food cultures
  • Probiotic ingredients
  • Natural food colors
  • Food enzymes
  • Biosolutions fermentation

Where Chr. Hansen is headquartered

Location

Headquarters

HQ city
Hørsholm
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

Chr. Hansen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales

Revenue model

  1. Probiotic ingredients B2B: Chr. Hansen supplies probiotic ingredients to food, nutraceutical, and cosmetic manufacturers through fermentation scale, IP-protected strains, and B2B partnerships
  2. Natural food colors: Major manufacturers including Chr. Hansen maintain competitive advantages through integrated sourcing networks, proprietary processing capabilities, and economies of scale for natural food coloring ingredients
  3. Food cultures and bacterial cultures: Supply of lactic acid bacteria and microbial food cultures for dairy and plant-based dairy alternatives, with Chr. Hansen leading the competitive landscape with 24-28% market share

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Chr. Hansen product offering

Product offering

Core offering

Chr. Hansen manufactures and sells microbial cultures, food enzymes, natural food colors, and probiotic ingredients for B2B customers across food & beverage, human health, animal nutrition, and agricultural industries. The portfolio includes the BB-12™ probiotic strain, FreshQ® 5.0 protective cultures, lactic acid bacteria for dairy fermentation, silage inoculants, and spirulina-based colorants, organized into biosolutions verticals including Food & Beverages, Human Health, Animal & Plant, Bioenergy, Household Care, and Industrial Bioprocessing.

Product overview

Chr. Hansen (now part of Novonesis following its merger with Novozymes in 2023-2024) operates as a biosolutions company offering a broad portfolio of microbial ingredients, enzymes, and natural food colors. The company's offerings span multiple industry verticals including Food & Beverages (bacterial cultures, food enzymes, natural colors), Human Health (probiotics including the documented BB-12™ strain), Animal & Plant (silage inoculants, feed enzymes), Bioenergy (enzymes for biofuel production), Household Care, and Industrial Bioprocessing. The portfolio includes platform products like FreshQ® 5.0 protective cultures for clean-label preservation. The combined entity positions itself as a leader in biosolutions addressing food systems, health, and sustainability challenges.

Differentiator

Problem solved

Functional benefit

Products and services

  • BB-12™ Probiotic Strain The world's most documented Bifidobacterium probiotic strain, used in dietary supplements, functional foods, and beverages for gut health applications. Targeted at human health manufacturers and nutraceutical brands.
  • FreshQ® 5.0 Protective Cultures

Quantifiable outcome

  • Leading 24-28% market share in global food cultures market
  • +1 more outcomes

Companies that use Chr. Hansen

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Chr. Hansen technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Chr. Hansen partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • dsm-firmenichcoreStrategic or Co-development Partner · 1 January 2025Novonesis and dsm-firmenich have worked together for over 25 years on innovating and distributing enzymes for animals as the Feed Enzyme Alliance. Novonesis acquired dsm-firmenich's animal feed enzyme business, bringing sales and distribution activities under the same roof as research and innovation.
  • UPL Ltd.minorStrategic or Co-development Partner · 1 January 2025Bio-based crop protection partnership between UPL Ltd. and Chr. Hansen Holding A/S, reflecting the industry's shift toward sustainable and resistance-managed formulations.
  • DanonecoreStrategic or Co-development Partner · 21 November 2024Danone teamed up with Chr. Hansen on dairy and plant-based innovation as part of the Partner for Growth initiative, focusing on developing new probiotic and culture solutions for dairy and plant-based products.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Chr. Hansen competitors and assessment

Company assessment

Direct peers

  • Novozymes: Now merged with Chr. Hansen to form Novonesis. Was historically the most direct peer in industrial enzymes and microbial solutions, serving overlapping food, beverage, animal nutrition, and bioenergy customers globally.
  • Lesaffre: Privately held French global leader in yeast and fermentation products. Directly comparable as a B2B supplier of microbial cultures, probiotics, and fermentation ingredients to food, bakery, and nutraceutical manufacturers.
  • Lallemand: Canadian family-owned yeast and bacteria producer with a major probiotics and fermented functional ingredients business. Overlaps with Chr. Hansen in dairy cultures, human probiotics (incl. L. rhamnosus GG), and animal nutrition.
  • dsm-firmenich: Dutch-Swiss specialty nutrition and health ingredients major; 25-year Feed Enzyme Alliance partner with Chr. Hansen before divesting animal feed enzymes to Novonesis. Comparable across animal nutrition, human health probiotics (i-Health), and food enzymes.
  • Corbion: Dutch specialty ingredient company producing lactic acid, functional ingredients, and microbial solutions for food and personal care. Directly comparable in dairy cultures and fermentation-derived food ingredients.

Broad incumbents

  • International Flavors & Fragrances (IFF): Global ingredient major following the DuPont Nutrition & Biosciences merger; offers cultures, enzymes, and probiotics through the Health & Biosciences division. Competes with Chr. Hansen across dairy cultures and food enzymes for major CPG customers.
  • Kerry Group: Irish taste & nutrition major serving food and beverage manufacturers. Comparable as a broad-line B2B ingredient supplier with probiotics, enzymes, and functional ingredient portfolios competing for similar CPG wallet share.
  • ADM (Archer Daniels Midland): Global agribusiness major with a Human Nutrition and Health & Wellness ingredients portfolio including probiotics (Biopolis) and natural colors. Comparable as a broad-line supplier to food, beverage, and nutraceutical manufacturers.

Regional players

  • AB Mauri: Baking yeast and ingredient arm of Associated British Foods. Comparable as a global microbial/baking ingredient supplier with overlapping food cultures and bakery ingredient customers.

Emerging players

  • Evonik Industries: German specialty chemicals company with a probiotics (Evonik Probiotics) and animal nutrition business. Overlaps with Chr. Hansen in animal health probiotics and gut-health ingredients, serving feed and supplement markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Chr. Hansen social profiles

Digital presence

Chr. Hansen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chr. Hansen leadership team

Management profile

Number of profiles

Profiles7 records

Chr. Hansen subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Chr. Hansen funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chr. Hansen M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chr. Hansen

What does Chr. Hansen do?

Chr. Hansen manufactures and sells microbial cultures, food enzymes, natural food colors, and probiotic ingredients for B2B customers across food & beverage, human health, animal nutrition, and agricultural industries. The portfolio includes the BB-12™ probiotic strain, FreshQ® 5.0 protective cultures, lactic acid bacteria for dairy fermentation, silage inoculants, and spirulina-based colorants, organized into biosolutions verticals including Food & Beverages, Human Health, Animal & Plant, Bioenergy, Household Care, and Industrial Bioprocessing.

Is Chr. Hansen a public or private company?

Chr. Hansen is a public company. It is classified as corporate owned and is currently operating.

When was Chr. Hansen founded?

Chr. Hansen was founded in 1878. It employs 5,001 to 10,000 people.

Where is Chr. Hansen based?

Chr. Hansen is headquartered in Hørsholm, Denmark, in the Europe region.

How does Chr. Hansen make money?

Three revenue lines are on record. Probiotic ingredients B2B is the primary driver. The others are natural food colors and food cultures and bacterial cultures.

Who are Chr. Hansen's main competitors?

Direct peers on record are Novozymes, Lesaffre, Lallemand, dsm-firmenich and Corbion. Broad incumbents are International Flavors & Fragrances (IFF), Kerry Group and ADM (Archer Daniels Midland). AB Mauri is listed as a regional player. Evonik Industries is listed as an emerging player.

Does Chr. Hansen have an API?

No public API is recorded for Chr. Hansen.

What industry is Chr. Hansen in?

Chr. Hansen's product category is Industrial Biotechnology / Food Bioscience Ingredients. Its primary akta.pro industry code is AFAJAJAE, Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ticker ReportChr. Hansen Holding A/S (OTCMKTS:CHYHY) Shares Up 0.8% – Here’s What HappenedChr. Hansen Holding A/S shares rose 0.8% to $19.5850 during mid-day trading on Wednesday, with the stock reaching $19.86. Volume fell 47% to 7,300 shares, down from the average 13,855. The company, a Danish bioscience firm, produces natural ingredients for food, health, and agriculture.Markets DailyChr. Hansen Holding A/S (OTCMKTS:CHYHY) Shares Up 0.8% – Still a Buy?Chr. Hansen Holding A/S shares rose 0.8% on Wednesday, trading at $19.5850, with volume down 47% from average. The global bioscience company, founded in 1874, operates across cultures, health, and natural colors segments.EIN PresswireFermentation Chemicals Market to Register 4.95% CAGR During 2026–2035The global fermentation chemicals market is projected to grow from $216.17 billion in 2025 to $345.82 billion by 2035, a 4.95% CAGR. Alcohols hold the largest segment share at ~42%, while enzymes are the fastest-growing product type. North America leads with ~34% market share, and Asia-Pacific is the fastest-growing region.PrtimesDairy Starter Culture Market to Grow at a CAGR of 6.7% Through 2034 – PR TimesThe global dairy starter culture market is projected to grow from USD 1.17 billion in 2025 to USD 1.72 billion by 2034, driven by rising consumer demand for probiotic-rich functional dairy products and clean-label ingredients. Chr. Hansen dominates the competitive landscape with over 40% market share, while key players include DSM, Danisco (IFF), and Lallemand Inc. The report highlights significant growth opportunities in the Asia-Pacific region and the expanding application of starter cultures in plant-based dairy alternatives.TalkMarketsProbiotics Market Growth Analysis by Product TypeThe global probiotics market was valued at USD 114.0 billion in 2025 and is projected to reach USD 301.2 billion by 2033, growing at a CAGR of 12.8%, according to market research by Grand View Research. Asia Pacific led the market with a 39.1% revenue share in 2025, with China identified as the largest country-level market, while the human probiotics segment held 81.4% and probiotic food and beverages accounted for 57.9% of total revenue. Key industry participants include Arla Foods, BioGaia, Chr. Hansen Holding, Danone, DuPont de Nemours, General Mills, i-Health, Lallemand, Lifeway Foods, and Nestlé, as companies increasingly invest in personalized nutrition, clinical research, and functional food innovation to capture market share.FmiblogHow Sensient and Chr. Hansen Control Natural Food Colour Pricing While Agricultural Costs Drive Supply Chain VulnerabilitiesThe global Natural Food Colors market is undergoing transformation as extraction technology, agricultural supply conditions, regulatory compliance, and brand positioning reshape pricing structures across the food and beverage industry. Major manufacturers Sensient and Chr. Hansen maintain competitive advantages through integrated sourcing networks, proprietary processing capabilities, and economies of scale, while smaller producers face increasing pressure from agricultural volatility, compliance requirements, and technology investment costs. Consumer preference for clean-label and natural ingredients continues to drive demand, supporting premium pricing for established suppliers with strong technical expertise and regulatory infrastructure.VerifiedmarketreportsGlobal Natural Colorant Market Size, Share & Industry Forecast 2026-2034The global natural colorant market is projected to grow from USD 3.1 billion in 2025 to USD 6.3 billion by 2033, representing a compound annual growth rate of approximately 7.8% during 2026-2033, driven by regulatory restrictions on synthetic dyes, consumer demand for clean-label products, and technological innovations in extraction and stabilization. Major industry players including Chr. Hansen, Givaudan, Symrise, and Nestlé are actively expanding their natural colorant portfolios through product launches, strategic partnerships, and capacity expansions to capture market share in this rapidly evolving sector. The market is transitioning from a niche segment to a mainstream industry component, with consolidation trends emerging as key players acquire smaller innovative firms to secure supply chains and expand applications across food, cosmetics, pharmaceuticals, and textiles.FortunebusinessinsightsProbiotics Food & Cosmetics Market Size, ShareThe global probiotics food and cosmetics market was valued at USD 71.01 billion in 2025 and is projected to grow to USD 118.08 billion by 2034, exhibiting a CAGR of 5.84%, with Asia Pacific dominating at 48.61% market share. Key industry players including Chr. Hansen Holding A/S, DSM-Firmenich, Yakult Honsha Co., Ltd., Lallemand Inc., and Kerry Group collectively shape global supply through fermentation scale, IP-protected strains, and B2B partnerships with food, nutraceutical, and cosmetic manufacturers. Recent developments include Bausch Health's September 2025 launch of the YUN Probiotherapy ACN skincare line in Poland through a partnership with YUN NV, and Leucine Rich Bio's launch of India's first microbiome-based skincare product, highlighting accelerating convergence of nutrition science and dermatology across functional foods and cosmetics.Straits ResearchProbiotics Market Size, Share, Growth, Analysis, Report, 2034The global probiotics market was valued at USD 78.01 billion in 2025 and is projected to reach USD 147.07 billion by 2034, growing at a compound annual growth rate of 7.3% during the forecast period 2026-2034. Asia-Pacific leads the market with a 39.1% share in 2024, while Europe is identified as the fastest-growing region with a projected CAGR of 6.9%. Key market segments include probiotic food and beverages (61.5% market share), bacteria-based ingredients (dominant share), and hypermarkets/supermarkets as the leading distribution channel (38.3% share), with major players including Danone, Nestle S.A, Chr. Hansen Holding A/S, and Yakult Honsha Co. Ltd.GlobeNewswireGlobal Probiotics Market Analysis Report 2026, Profiles of Chr. Hansen, BioGaia, Probi, Yakult Honsha, Nestle, Danone, LallemandThe Global Probiotics Market is experiencing robust growth driven by increasing health awareness, demand for functional foods, and expanding applications in human and animal health, with the market projected to grow significantly through 2031. The industry is witnessing innovation in product formats, personalized probiotics, and delivery technologies, while leading companies including Danone, Nestle, and Chr. Hansen are investing heavily in clinical research and R&D to substantiate health claims. Asia Pacific represents the fastest-growing regional market, led by China, Japan, India, and South Korea, while North America and Europe remain mature markets with high consumer awareness and preference for clean-label products.